Lauren Biscaldi is the Managing Editor of Drug Topics.
Breaking: HHS Extends PREP Act Authority for Pharmacists, Pharmacy Technicians
HHS Secretary Xavier Becerra will release an amendment to the declaration in the coming weeks.
AAP Members Celebrate Their Independent Pharmacy Stories
Four independent pharmacists shared their journeys to become pharmacy owners.
Biden Administration Announces $5 Billion Investment in COVID-19 Vaccine, Treatment Development
Project NextGen will focus on the development of vaccines and long-lasting monoclonal antibody COVID-19 treatments.
Last Chance to Register: Don’t Miss the Next Total Pharmacy Solutions Summit
The theme of the upcoming Summit is the Expansion of Services Within Independent Pharmacy.
Video: Tips for Medication Management During Ramadan
Pharmacists can provide support and guidance to patients during their month of fasting.
Breaking: FDA Approves OTC Designation for Naloxone Nasal Spray
Naloxone hydrochloride nasal spray (Narcan) 4 mg is expected to be available over the counter in late summer 2023.
Pharmacy’s Role in Managing Medical Misinformation
Are pharmacists obligated to correct medical misinformation they encounter online?
Vaccines, Variants, and More: COVID-19 Year in Review
From variants to vaccines, much has changed in the COVID-19 landscape.
Pharmacogenetic Testing, Therapeutic Drug Monitoring Feasible to Monitor Sertraline Concentrations in Residential Treatment Setting
Pharmacogenetic testing and therapeutic drug monitoring are feasible in the inpatient psychiatric treatment setting.
COVID-19 Stay-At-Home Orders Increased EMS Utilization in United States
Emergency medical services runs increased in all 4 US Census regions.
Prophylactic Benzodiazepine Use May Reduce Seizures in Bupropion Overdose
It is crucial to have a measure to mitigate the possibility of seizures, according to researchers.
Pharmacist Knowledge of Psilocybin Remains Limited
Survey respondents indicated a lack of comfort around recommending psilocybin therapy to patients.
Celebrate Your Story at the American Associated Pharmacies 2023 Annual Conference
The 2023 AAP Annual Conference will take place in New Orleans from April 20 to 22.
Welcome to Phoenix: Things to Do at APhA 2023
As sessions end for the day, head out to explore the city of Phoenix.
Meeting Preview: APhA 2023
APhA 2023 will take place March 24 to March 27 in Phoenix, Arizona
Safety, Accuracy of Dexcom G7 CGM Evaluated in T1D and T2D
The CGM provides accurate readings over 10.5 days of continuous wear.
FDA Approves Expanded Indication for Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer
The expansion was based on 4-year data from the monarchE study.
Rivaroxaban Plus Aspirin Reduces Acute Limb Ischemia After Lower Extremity Revascularization in PAD
Results of an analysis of the VOYAGER PAD clinical trial were presented at ACC.23.
FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion
The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.
Register Today to Attend the Next Total Pharmacy® Solutions Summit
The Total Pharmacy® Solutions Summit will take place on April 8, 2023.
How a Bill Becomes a Law: Pharmacy Legislation to Watch
FDA Accepts Supplemental BLA For Nivolumab For Melanoma
The PDFUA date for the drug is October 13, 2023.
ASHP CEO Urges Biden Administration to Utilize Pharmacists as Care Providers in Opioid Epidemic
The letter outlined 7 steps that the Biden administration can take without the need for additional legislation.
Pharmacy Organizations Partner to Reaffirm Commitment to DEI at All Levels of Health Care
The groups released 8 recommendations to support action across the health care community.
Bills Safety Damar Hamlin Launches #3forHeart CPR Challenge
After an on-field cardiac arrest, Hamlin partnered with the American Heart Association to spotlight the importance of CPR
Prioritizing Culturally Competent Care, Advocacy, and Access in HIV
To sufficiently address HIV, stakeholders across the health care spectrum must come together.
First Adalimumab Biosimilar Launches in US Market
Adalimumab-atto was first approved by the FDA in 2016.
Breaking: FDA Committee Votes in Favor of New, Unified COVID-19 Vaccine Strategy
Recommendations from the unanimous vote must be adopted by the FDA and CDC.
Examining the Global Burden of Long COVID by Sex
Investigators analyzed the proportion of individuals with 1 of 3 clusters of Long COVID symptoms.
Bexagliflozin Approval Creates New SGLT2 Inhibitor Option for Adults With T2D
The new medication reduces HbA1c and improves glycemic control as an adjunct to diet and exercise.